Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd

This study tested a new vaccine that protects against 26 types of pneumococcal bacteria, which can cause pneumonia and other infections. About 450 people aged 2 months and older received the vaccine to check its safety and how well it triggers the immune system. The trial is comp…